Biological Information

Background Information:

Estrogen receptors are members of a superfamily of nuclear receptors that transduce the effects of a diverse array of small, hydrophobic ligands, including the steroid hormones, thyroid hormone, vitamin D and retinoids. Estrogen receptor agonists may alter the menstrual cycle, prevent conception, decrease bone resorption and increase risk of breast cancer in females while antagonists may alter the menstrual cycle and be useful in the treatment of breast cancer.

Family:

NHR

Sub Family:

Estrogen

Class:

Steroid

Protein Name:

ERalpha

Uniprot Number:

P03372

Protein Aliases:

ER-alpha|Estradiol receptor|Nuclear receptor subfamily 3 group A member 1

Gene Name:

ESR1

Gene ID:

2099

Gene Aliases:

NR3A1|Era

Accession Number:

NM_001328100

Organism:

Human

Construct Details:

Full Length, Recombinant

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Binding

Detection Method:

Radiometry

Measured Response:

Scintillation

Testing Information

Procedure Summary:

Human recombinant Estrogen a (ERa) receptors expressed in Sf9 insect cells are used in modified Tris-HCl buffer pH 7.4. A 9.6 ng‡ aliquot is incubated with 0.5 nM [³H] Estradiol for 2 hours at 25°C. Non-specific binding is estimated in the presence of 1 µM diethylstilbestrol. Receptor proteins are filtered and washed, the filters are then counted to determine [³H] Estradiol specifically bound. Compounds are screened at 10 µM.
Note: ‡Membrane protein may change from lot to lot, the concentration used will be adjusted if necessary.

Ligand:

[³H] Estradiol

Ligand Kd (nM):

0.2

Ligand Concentration:

0.5 nM

Non Specific:

1 µM Diethylstilbestrol

Incubation:

120 min at 25°C

Control Inhibitor:

Diethylstilbestrol

Criteria For Significance:

≥ 50% of max stimulation or inhibition

Test Concentration / Dose:

Suggested concentration for initial testing is 10 uM

Test Sample Requirements:

Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).

Minimum Order Quantity:

2

Turnaround Time

Standard:

15 Business Days

Reference Compound Data

PubChem ID

5757

Name

Estradiol

Measurement

0.00074μM - IC50

PubChem ID

5991

Name

Ethinyl estradiol

Measurement

0.00082μM - IC50

PubChem ID

68570

Name

Epiestradiol

Measurement

0.00048μM - IC50

PubChem ID

448537

Name

Diethylstilbestrol

Measurement

0.00077μM - IC50

PubChem ID

2733526

Name

Tamoxifen

Measurement

0.01μM - IC50

Clinical Relevance

Therapeutic Area:

Metabolic Diseases

Adverse / Beneficial Action:

Estrogen receptor agonists may alter the menstrual cycle, prevent conception, decrease bone resorption and increase risk of breast cancer in females while antagonists may alter the menstrual cycle and be useful in the treatment of breast cancer.

Additional Information

Brand:

LeadHunter

Testing Location:

Taiwan - Taipei

RELATED SOLUTIONS

Item: PP16
Item: PP68
Item: PP89
Item: PP116
Item: PP152
Item: PP223
Item: 311410-0
Item: 311410-1
Item: 311410